{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:08:06Z","timestamp":1771632486091,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATVB"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Objective\u2014<\/jats:italic>\n            <\/jats:bold>\n            Studies in mice have shown that genetic disruption of monocyte chemotactic protein-1 or its receptor, the C-C chemokine receptor 2 (CCR2), inhibits atherosclerosis, but few data exist in humans to suggest that the monocyte chemotactic protein-1\u2014CCR2 interaction is important in atherogenesis. A common polymorphism in the human CCR2 gene resulting in a substitution of isoleucine for valine (Val64Ile) has been associated with other disease phenotypes in humans.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods and Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            A cohort of first-degree relatives of persons with premature coronary artery disease was recruited and quantitatively phenotyped for the extent of CAC, a marker of coronary atherosclerosis, by using electron beam CT. The extent of CAC was significantly lower in subjects with the CCR2-Ile64 variant (Val\/Ile and Ile\/Ile genotypes) than in subjects carrying 2 Val64 alleles, even after adjustment for traditional risk factors.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            This study provides genetic evidence linking CCR2 with coronary atherosclerosis in humans.\n          <\/jats:p>","DOI":"10.1161\/01.atv.0000038486.48400.e7","type":"journal-article","created":{"date-parts":[[2002,11,8]],"date-time":"2002-11-08T22:24:53Z","timestamp":1036794293000},"page":"1924-1928","source":"Crossref","is-referenced-by-count":60,"title":["Val64Ile Polymorphism in the C-C Chemokine Receptor 2 Is Associated With Reduced Coronary Artery Calcification"],"prefix":"10.1161","volume":"22","author":[{"given":"Ana M.","family":"Valdes","sequence":"first","affiliation":[{"name":"From GlaxoSmithKline (A.M.V., E.J.O., N.K.S., A.R., P.H.E.G.), Stevenage, Hertfordshire, UK, and the University of Pennsylvania School of Medicine (M.L.W., W.G., D.J.R.), Philadelphia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan L.","family":"Wolfe","sequence":"additional","affiliation":[{"name":"From GlaxoSmithKline (A.M.V., E.J.O., N.K.S., A.R., P.H.E.G.), Stevenage, Hertfordshire, UK, and the University of Pennsylvania School of Medicine (M.L.W., W.G., D.J.R.), Philadelphia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eamonn J.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"From GlaxoSmithKline (A.M.V., E.J.O., N.K.S., A.R., P.H.E.G.), Stevenage, Hertfordshire, UK, and the University of Pennsylvania School of Medicine (M.L.W., W.G., D.J.R.), Philadelphia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel K.","family":"Spurr","sequence":"additional","affiliation":[{"name":"From GlaxoSmithKline (A.M.V., E.J.O., N.K.S., A.R., P.H.E.G.), Stevenage, Hertfordshire, UK, and the University of Pennsylvania School of Medicine (M.L.W., W.G., D.J.R.), Philadelphia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren","family":"Gefter","sequence":"additional","affiliation":[{"name":"From GlaxoSmithKline (A.M.V., E.J.O., N.K.S., A.R., P.H.E.G.), Stevenage, Hertfordshire, UK, and the University of Pennsylvania School of Medicine (M.L.W., W.G., D.J.R.), Philadelphia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Rut","sequence":"additional","affiliation":[{"name":"From GlaxoSmithKline (A.M.V., E.J.O., N.K.S., A.R., P.H.E.G.), Stevenage, Hertfordshire, UK, and the University of Pennsylvania School of Medicine (M.L.W., W.G., D.J.R.), Philadelphia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter H.E.","family":"Groot","sequence":"additional","affiliation":[{"name":"From GlaxoSmithKline (A.M.V., E.J.O., N.K.S., A.R., P.H.E.G.), Stevenage, Hertfordshire, UK, and the University of Pennsylvania School of Medicine (M.L.W., W.G., D.J.R.), Philadelphia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Rader","sequence":"additional","affiliation":[{"name":"From GlaxoSmithKline (A.M.V., E.J.O., N.K.S., A.R., P.H.E.G.), Stevenage, Hertfordshire, UK, and the University of Pennsylvania School of Medicine (M.L.W., W.G., D.J.R.), Philadelphia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404143301503"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng827"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00346-9"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115411"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.12.5252"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.7.2752"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/29788"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5624"},{"key":"e_1_3_3_9_2","first-page":"275","volume":"2","year":"1998","journal-title":"Mol Cell Biol"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(98)00318-9"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.0000015099.41408.31"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5328.959"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000022932"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.6.9810020"},{"key":"e_1_3_3_15_2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1681\/ASN.V133754","volume":"13","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"e_1_3_3_16_2","first-page":"1175","volume":"94","year":"1996","journal-title":"Writing Group Circulation"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.95.2.297"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.92.8.2157"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.192.3.8058924"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00067-4"},{"key":"e_1_3_3_21_2","first-page":"325","volume":"11","year":"2001","journal-title":"Ethn Dis"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.2310\/6650.2001.33901"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90282-T"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/19.19.5444"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.97.18.1837"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.19.2546"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.9.1608"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.22.3.418"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-002-0731-5"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/genetics\/139.1.463","volume":"139","year":"1995","journal-title":"Genetics"}],"container-title":["Arteriosclerosis, Thrombosis, and Vascular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.ATV.0000038486.48400.E7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T18:11:26Z","timestamp":1647540686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.ATV.0000038486.48400.E7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1161\/01.ATV.0000038486.48400.E7"],"URL":"https:\/\/doi.org\/10.1161\/01.atv.0000038486.48400.e7","relation":{},"ISSN":["1079-5642","1524-4636"],"issn-type":[{"value":"1079-5642","type":"print"},{"value":"1524-4636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}